GPX4 and cancer: Previous studies have shown that the high expression of ALOX5 is closely associated with ferroptosis sensitivity [42, 43], and ferroptosis is also closely linked to chemoresistance in cancer cells [14, 19, 44, 45], with chemoresistant cancer cells being more susceptible to GPX4 inhibition.